{
  "metadata": {
    "version": "1.0",
    "date_created": "2025-11-08",
    "source": "Comprehensive aging research analysis",
    "total_biomarkers": 89,
    "categories": ["epigenetic", "metabolic", "proteomic", "cellular", "inflammatory", "cardiovascular", "hormonal", "genetic", "mitochondrial"]
  },
  "biomarkers": [
    {
      "id": 1,
      "name": "Horvath DNAm Clock",
      "category": "epigenetic",
      "subcategory": "methylation_clock",
      "measurement_method": "Illumina EPIC Array (DNA methylation at 353 CpG sites)",
      "specimen_type": "blood",
      "normal_range_20s": {"biological_age": "18-25", "unit": "years"},
      "normal_range_40s": {"biological_age": "38-45", "unit": "years"},
      "normal_range_60s": {"biological_age": "58-65", "unit": "years"},
      "normal_range_80s": {"biological_age": "78-85", "unit": "years"},
      "clinical_validation_level": "clinically-validated",
      "evidence_grade": "A",
      "predictive_power": 0.85,
      "cost_per_test": 300,
      "turnaround_time_days": 14,
      "insurance_coverage": "rarely-covered",
      "direction_with_age": "increases",
      "pathological_threshold": ">10 years acceleration from chronological age",
      "optimal_range": "Within 3.6 years of chronological age",
      "citations": ["PMID:24138928"],
      "first_discovered": 2013,
      "notes": "Pan-tissue biological age predictor. Accuracy ±3.6 years"
    },
    {
      "id": 2,
      "name": "GrimAge Clock",
      "category": "epigenetic",
      "subcategory": "methylation_clock",
      "measurement_method": "DNA methylation array",
      "specimen_type": "blood",
      "clinical_validation_level": "clinically-validated",
      "evidence_grade": "A",
      "predictive_power": 0.90,
      "cost_per_test": 300,
      "turnaround_time_days": 14,
      "insurance_coverage": "rarely-covered",
      "direction_with_age": "increases",
      "notes": "Best predictor of mortality and healthspan among epigenetic clocks"
    },
    {
      "id": 3,
      "name": "PhenoAge Clock",
      "category": "epigenetic",
      "subcategory": "methylation_clock",
      "measurement_method": "DNA methylation array",
      "specimen_type": "blood",
      "clinical_validation_level": "clinically-validated",
      "evidence_grade": "A",
      "predictive_power": 0.87,
      "cost_per_test": 300,
      "turnaround_time_days": 14,
      "insurance_coverage": "rarely-covered",
      "direction_with_age": "increases",
      "notes": "Composite clinical biomarkers + DNA methylation"
    },
    {
      "id": 4,
      "name": "Telomere Length",
      "category": "cellular",
      "subcategory": "DNA_integrity",
      "measurement_method": "Flow-FISH or qPCR (T/S ratio)",
      "specimen_type": "blood",
      "normal_range_20s": {"min": 7500, "max": 8500, "unit": "bp"},
      "normal_range_40s": {"min": 6300, "max": 7300, "unit": "bp"},
      "normal_range_60s": {"min": 5100, "max": 6100, "unit": "bp"},
      "normal_range_80s": {"min": 3900, "max": 4900, "unit": "bp"},
      "clinical_validation_level": "FDA-approved",
      "evidence_grade": "A",
      "predictive_power": 0.72,
      "cost_per_test": 200,
      "turnaround_time_days": 7,
      "insurance_coverage": "sometimes-covered",
      "direction_with_age": "decreases",
      "pathological_threshold": "<4000 bp critical senescence threshold",
      "optimal_range": "Age-appropriate length (64±3 bp/year decline)",
      "citations": ["RepeatDx Flow-FISH reference"],
      "notes": "Flow-FISH superior to qPCR for clinical use (CV <5%)"
    },
    {
      "id": 5,
      "name": "p16INK4a T-cell expression",
      "category": "cellular",
      "subcategory": "senescence",
      "measurement_method": "RT-qPCR (p16_variant 5 mRNA)",
      "specimen_type": "blood",
      "normal_range_20s": {"expression": "low", "fold_change": 1.0},
      "normal_range_40s": {"expression": "moderate", "fold_change": 2.8},
      "normal_range_60s": {"expression": "high", "fold_change": 8.0},
      "normal_range_80s": {"expression": "very high", "fold_change": 16.0},
      "clinical_validation_level": "clinically-validated",
      "evidence_grade": "A",
      "predictive_power": 0.78,
      "cost_per_test": 150,
      "turnaround_time_days": 5,
      "insurance_coverage": "rarely-covered",
      "direction_with_age": "increases",
      "pathological_threshold": "Upper tertile (predicts senolytic response)",
      "notes": "Doubles every ~8 years. Predicts response to dasatinib+quercetin"
    },
    {
      "id": 6,
      "name": "IL-6 (Interleukin-6)",
      "category": "inflammatory",
      "subcategory": "cytokine",
      "measurement_method": "ELISA or multiplex immunoassay",
      "specimen_type": "blood",
      "normal_range_20s": {"min": 0, "max": 1.5, "unit": "pg/mL"},
      "normal_range_40s": {"min": 0, "max": 5.0, "unit": "pg/mL"},
      "normal_range_60s": {"min": 0, "max": 10.0, "unit": "pg/mL"},
      "normal_range_80s": {"min": 0, "max": 17.4, "unit": "pg/mL"},
      "clinical_validation_level": "FDA-approved",
      "evidence_grade": "A",
      "predictive_power": 0.73,
      "cost_per_test": 75,
      "turnaround_time_days": 3,
      "insurance_coverage": "typically-covered",
      "direction_with_age": "increases",
      "pathological_threshold": ">17.4 pg/mL",
      "citations": ["Multiple systematic reviews"],
      "notes": "The cytokine for gerontologists. Central to inflammaging"
    },
    {
      "id": 7,
      "name": "CRP (C-Reactive Protein)",
      "category": "inflammatory",
      "subcategory": "acute_phase",
      "measurement_method": "High-sensitivity immunoassay (hs-CRP)",
      "specimen_type": "blood",
      "normal_range_20s": {"min": 0, "max": 1.0, "unit": "mg/L"},
      "normal_range_40s": {"min": 0, "max": 1.5, "unit": "mg/L"},
      "normal_range_60s": {"min": 0, "max": 2.5, "unit": "mg/L"},
      "normal_range_80s": {"min": 0, "max": 3.0, "unit": "mg/L"},
      "clinical_validation_level": "FDA-approved",
      "evidence_grade": "A",
      "predictive_power": 0.70,
      "cost_per_test": 25,
      "turnaround_time_days": 1,
      "insurance_coverage": "typically-covered",
      "direction_with_age": "increases",
      "pathological_threshold": ">3.0 mg/L (high CVD risk)",
      "notes": "Standard marker of systemic inflammation"
    },
    {
      "id": 8,
      "name": "TNF-α (Tumor Necrosis Factor-alpha)",
      "category": "inflammatory",
      "subcategory": "cytokine",
      "measurement_method": "ELISA or multiplex immunoassay",
      "specimen_type": "blood",
      "clinical_validation_level": "clinically-validated",
      "evidence_grade": "A",
      "predictive_power": 0.68,
      "cost_per_test": 80,
      "turnaround_time_days": 3,
      "insurance_coverage": "sometimes-covered",
      "direction_with_age": "increases",
      "notes": "Pro-inflammatory cytokine, NF-κB pathway activation"
    },
    {
      "id": 9,
      "name": "GDF15 (Growth Differentiation Factor 15)",
      "category": "proteomic",
      "subcategory": "SASP_factor",
      "measurement_method": "ELISA",
      "specimen_type": "blood",
      "clinical_validation_level": "clinically-validated",
      "evidence_grade": "A",
      "predictive_power": 0.82,
      "cost_per_test": 200,
      "turnaround_time_days": 5,
      "insurance_coverage": "rarely-covered",
      "direction_with_age": "increases",
      "notes": "Strongest mortality-associated SASP biomarker from senescent cells"
    },
    {
      "id": 10,
      "name": "NAD+ (Blood)",
      "category": "metabolic",
      "subcategory": "coenzyme",
      "measurement_method": "HPLC or LC-MS",
      "specimen_type": "blood",
      "normal_range_20s": {"relative": 100, "unit": "% of peak"},
      "normal_range_40s": {"relative": 75, "unit": "% of peak"},
      "normal_range_60s": {"relative": 50, "unit": "% of peak"},
      "normal_range_80s": {"relative": 20, "unit": "% of peak"},
      "clinical_validation_level": "research-use",
      "evidence_grade": "B",
      "predictive_power": 0.65,
      "cost_per_test": 300,
      "turnaround_time_days": 14,
      "insurance_coverage": "not-covered",
      "direction_with_age": "decreases",
      "pathological_threshold": "<50% of youthful levels",
      "notes": "50-80% decline by age 70-80. Critical for sirtuin and PARP function"
    },
    {
      "id": 11,
      "name": "Pulse Wave Velocity (PWV)",
      "category": "cardiovascular",
      "subcategory": "vascular_stiffness",
      "measurement_method": "Carotid-femoral tonometry",
      "specimen_type": "imaging",
      "normal_range_20s": {"min": 6.5, "max": 7.5, "unit": "m/s"},
      "normal_range_40s": {"min": 7.5, "max": 8.5, "unit": "m/s"},
      "normal_range_60s": {"min": 8.5, "max": 10.0, "unit": "m/s"},
      "normal_range_80s": {"min": 9.5, "max": 11.0, "unit": "m/s"},
      "clinical_validation_level": "FDA-approved",
      "evidence_grade": "A",
      "predictive_power": 0.77,
      "cost_per_test": 150,
      "turnaround_time_days": 0,
      "insurance_coverage": "sometimes-covered",
      "direction_with_age": "increases",
      "pathological_threshold": ">12 m/s (advanced vascular aging)",
      "citations": ["LIFE-Adult Study, n=8,509"],
      "notes": "Gold standard for arterial stiffness. 6-8% increase per decade"
    },
    {
      "id": 12,
      "name": "VO2 Max",
      "category": "cardiovascular",
      "subcategory": "cardiorespiratory_fitness",
      "measurement_method": "Cardiopulmonary exercise testing",
      "specimen_type": "imaging",
      "normal_range_20s": {"min": 35, "max": 45, "unit": "mL/kg/min"},
      "normal_range_40s": {"min": 30, "max": 38, "unit": "mL/kg/min"},
      "normal_range_60s": {"min": 22, "max": 30, "unit": "mL/kg/min"},
      "normal_range_80s": {"min": 15, "max": 22, "unit": "mL/kg/min"},
      "clinical_validation_level": "FDA-approved",
      "evidence_grade": "A",
      "predictive_power": 0.80,
      "cost_per_test": 300,
      "turnaround_time_days": 0,
      "insurance_coverage": "typically-covered",
      "direction_with_age": "decreases",
      "pathological_threshold": "<15 mL/kg/min (high risk)",
      "notes": "~10% decline per decade (sedentary), 5.5% (athletes). Exercise training: +16.3% increase"
    },
    {
      "id": 13,
      "name": "Heart Rate Variability (HRV)",
      "category": "cardiovascular",
      "subcategory": "autonomic_function",
      "measurement_method": "ECG or wearable device (RMSSD, SDNN)",
      "specimen_type": "imaging",
      "clinical_validation_level": "FDA-approved",
      "evidence_grade": "A",
      "predictive_power": 0.75,
      "cost_per_test": 50,
      "turnaround_time_days": 0,
      "insurance_coverage": "typically-covered",
      "direction_with_age": "decreases",
      "pathological_threshold": "<25th percentile for age",
      "notes": "Most significant decline between 2nd and 3rd decades. Low HRV: 4-9% higher lifetime CVD risk"
    },
    {
      "id": 14,
      "name": "Carotid Intima-Media Thickness (cIMT)",
      "category": "cardiovascular",
      "subcategory": "atherosclerosis",
      "measurement_method": "Ultrasound",
      "specimen_type": "imaging",
      "normal_range_20s": {"min": 0.4, "max": 0.6, "unit": "mm"},
      "normal_range_40s": {"min": 0.5, "max": 0.8, "unit": "mm"},
      "normal_range_60s": {"min": 0.7, "max": 1.1, "unit": "mm"},
      "normal_range_80s": {"min": 1.0, "max": 1.5, "unit": "mm"},
      "clinical_validation_level": "FDA-approved",
      "evidence_grade": "A",
      "predictive_power": 0.71,
      "cost_per_test": 200,
      "turnaround_time_days": 0,
      "insurance_coverage": "sometimes-covered",
      "direction_with_age": "increases",
      "pathological_threshold": ">1.5 mm (high atherosclerosis risk)",
      "citations": ["MESA study"],
      "notes": "2-3 fold increase from age 20-90"
    },
    {
      "id": 15,
      "name": "Testosterone (Total)",
      "category": "hormonal",
      "subcategory": "sex_hormone",
      "measurement_method": "Immunoassay or LC-MS",
      "specimen_type": "blood",
      "normal_range_20s": {"min": 300, "max": 1000, "unit": "ng/dL (men)"},
      "normal_range_40s": {"min": 250, "max": 850, "unit": "ng/dL (men)"},
      "normal_range_60s": {"min": 200, "max": 700, "unit": "ng/dL (men)"},
      "normal_range_80s": {"min": 150, "max": 600, "unit": "ng/dL (men)"},
      "clinical_validation_level": "FDA-approved",
      "evidence_grade": "A",
      "predictive_power": 0.68,
      "cost_per_test": 50,
      "turnaround_time_days": 2,
      "insurance_coverage": "typically-covered",
      "direction_with_age": "decreases",
      "pathological_threshold": "<300 ng/dL (hypogonadism in men)",
      "notes": "1-2% annual decline in men after 30. Women: 50% reduction by menopause"
    },
    {
      "id": 16,
      "name": "Estradiol (E2)",
      "category": "hormonal",
      "subcategory": "sex_hormone",
      "measurement_method": "Immunoassay or LC-MS",
      "specimen_type": "blood",
      "normal_range_20s": {"min": 30, "max": 400, "unit": "pg/mL (women, cycle-dependent)"},
      "normal_range_40s": {"min": 20, "max": 300, "unit": "pg/mL (perimenopause)"},
      "normal_range_60s": {"min": 0, "max": 30, "unit": "pg/mL (postmenopause)"},
      "normal_range_80s": {"min": 0, "max": 20, "unit": "pg/mL (postmenopause)"},
      "clinical_validation_level": "FDA-approved",
      "evidence_grade": "A",
      "predictive_power": 0.70,
      "cost_per_test": 50,
      "turnaround_time_days": 2,
      "insurance_coverage": "typically-covered",
      "direction_with_age": "decreases",
      "pathological_threshold": "<20 pg/mL (postmenopausal)",
      "notes": "Dramatic decline during perimenopause to 10-20% of premenopausal levels"
    },
    {
      "id": 17,
      "name": "IGF-1 (Insulin-like Growth Factor 1)",
      "category": "hormonal",
      "subcategory": "growth_hormone_axis",
      "measurement_method": "Immunoassay",
      "specimen_type": "blood",
      "clinical_validation_level": "FDA-approved",
      "evidence_grade": "A",
      "predictive_power": 0.65,
      "cost_per_test": 100,
      "turnaround_time_days": 3,
      "insurance_coverage": "typically-covered",
      "direction_with_age": "decreases",
      "notes": "29% decline per decade. Longevity paradox: reduced signaling associated with longevity"
    },
    {
      "id": 18,
      "name": "TSH (Thyroid Stimulating Hormone)",
      "category": "hormonal",
      "subcategory": "thyroid",
      "measurement_method": "Immunoassay",
      "specimen_type": "blood",
      "normal_range_20s": {"min": 0.4, "max": 3.6, "unit": "mIU/L"},
      "normal_range_40s": {"min": 0.4, "max": 4.0, "unit": "mIU/L"},
      "normal_range_60s": {"min": 0.4, "max": 5.0, "unit": "mIU/L"},
      "normal_range_80s": {"min": 0.4, "max": 7.5, "unit": "mIU/L"},
      "clinical_validation_level": "FDA-approved",
      "evidence_grade": "A",
      "predictive_power": 0.60,
      "cost_per_test": 30,
      "turnaround_time_days": 1,
      "insurance_coverage": "typically-covered",
      "direction_with_age": "increases",
      "pathological_threshold": ">7.0 mIU/L (elderly)",
      "citations": ["TRUST trial"],
      "notes": "Age-dependent reference ranges. Treatment threshold ≥7 mIU/L in elderly"
    },
    {
      "id": 19,
      "name": "Vitamin D (25-hydroxyvitamin D)",
      "category": "hormonal",
      "subcategory": "steroid_hormone",
      "measurement_method": "Immunoassay or LC-MS",
      "specimen_type": "blood",
      "normal_range_20s": {"min": 30, "max": 80, "unit": "ng/mL"},
      "normal_range_40s": {"min": 30, "max": 80, "unit": "ng/mL"},
      "normal_range_60s": {"min": 30, "max": 80, "unit": "ng/mL"},
      "normal_range_80s": {"min": 30, "max": 80, "unit": "ng/mL"},
      "clinical_validation_level": "FDA-approved",
      "evidence_grade": "A",
      "predictive_power": 0.68,
      "cost_per_test": 50,
      "turnaround_time_days": 2,
      "insurance_coverage": "typically-covered",
      "direction_with_age": "decreases",
      "pathological_threshold": "<20 ng/mL (deficiency)",
      "optimal_range": "30-50 ng/mL",
      "notes": "13% decrease per decade. By age 70: ~50% of age 20 production. 2024 guidelines: supplement >75 years"
    },
    {
      "id": 20,
      "name": "DHEA-S (Dehydroepiandrosterone Sulfate)",
      "category": "hormonal",
      "subcategory": "adrenal",
      "measurement_method": "Immunoassay",
      "specimen_type": "blood",
      "clinical_validation_level": "FDA-approved",
      "evidence_grade": "B",
      "predictive_power": 0.55,
      "cost_per_test": 60,
      "turnaround_time_days": 2,
      "insurance_coverage": "sometimes-covered",
      "direction_with_age": "decreases",
      "notes": "29% decline per decade. By age 70: ~20% of peak. By 85-90: 80-95% decline"
    },
    {
      "id": 21,
      "name": "Cortisol (Diurnal Pattern)",
      "category": "hormonal",
      "subcategory": "stress_hormone",
      "measurement_method": "Multiple salivary samples (awakening, throughout day)",
      "specimen_type": "saliva",
      "clinical_validation_level": "clinically-validated",
      "evidence_grade": "B",
      "predictive_power": 0.62,
      "cost_per_test": 100,
      "turnaround_time_days": 5,
      "insurance_coverage": "rarely-covered",
      "direction_with_age": "variable",
      "notes": "Basal hyperactivation with age. Flatter diurnal slope = dysregulation. Lower diurnal cortisol correlates with longevity"
    },
    {
      "id": 22,
      "name": "Glucose (Fasting)",
      "category": "metabolic",
      "subcategory": "glycemic_control",
      "measurement_method": "Glucose oxidase or hexokinase method",
      "specimen_type": "blood",
      "normal_range_20s": {"min": 70, "max": 100, "unit": "mg/dL"},
      "normal_range_40s": {"min": 70, "max": 100, "unit": "mg/dL"},
      "normal_range_60s": {"min": 70, "max": 105, "unit": "mg/dL"},
      "normal_range_80s": {"min": 70, "max": 110, "unit": "mg/dL"},
      "clinical_validation_level": "FDA-approved",
      "evidence_grade": "A",
      "predictive_power": 0.75,
      "cost_per_test": 10,
      "turnaround_time_days": 0,
      "insurance_coverage": "typically-covered",
      "direction_with_age": "increases",
      "pathological_threshold": "≥126 mg/dL (diabetes)",
      "notes": "Insulin resistance characteristic of normal aging"
    },
    {
      "id": 23,
      "name": "HbA1c (Glycated Hemoglobin)",
      "category": "metabolic",
      "subcategory": "glycemic_control",
      "measurement_method": "HPLC or immunoassay",
      "specimen_type": "blood",
      "normal_range_20s": {"min": 4.0, "max": 5.6, "unit": "%"},
      "normal_range_40s": {"min": 4.0, "max": 5.6, "unit": "%"},
      "normal_range_60s": {"min": 4.5, "max": 6.0, "unit": "%"},
      "normal_range_80s": {"min": 5.0, "max": 6.2, "unit": "%"},
      "clinical_validation_level": "FDA-approved",
      "evidence_grade": "A",
      "predictive_power": 0.78,
      "cost_per_test": 20,
      "turnaround_time_days": 1,
      "insurance_coverage": "typically-covered",
      "direction_with_age": "increases",
      "pathological_threshold": "≥6.5% (diabetes)",
      "notes": "3-month average glucose. Age-related increase due to insulin resistance"
    },
    {
      "id": 24,
      "name": "FOXO3A Genotype (rs2802292)",
      "category": "genetic",
      "subcategory": "longevity_gene",
      "measurement_method": "SNP genotyping",
      "specimen_type": "blood",
      "clinical_validation_level": "research-use",
      "evidence_grade": "A",
      "predictive_power": 0.65,
      "cost_per_test": 100,
      "turnaround_time_days": 14,
      "insurance_coverage": "not-covered",
      "direction_with_age": "stable",
      "notes": "Most robust longevity gene. G allele protective. Homozygous minor allele: OR=2.75 for longevity"
    },
    {
      "id": 25,
      "name": "APOE Genotype",
      "category": "genetic",
      "subcategory": "longevity_gene",
      "measurement_method": "SNP genotyping (rs429358, rs7412)",
      "specimen_type": "blood",
      "clinical_validation_level": "FDA-approved",
      "evidence_grade": "A",
      "predictive_power": 0.75,
      "cost_per_test": 200,
      "turnaround_time_days": 14,
      "insurance_coverage": "sometimes-covered",
      "direction_with_age": "stable",
      "notes": "ε2 protective (+1 year lifespan), ε4 detrimental (-1.2 years). ε4: 3-12x AD risk"
    },
    {
      "id": 26,
      "name": "Mitochondrial DNA Copy Number",
      "category": "mitochondrial",
      "subcategory": "mitochondrial_health",
      "measurement_method": "qPCR (mtDNA/nuclear DNA ratio)",
      "specimen_type": "blood",
      "clinical_validation_level": "research-use",
      "evidence_grade": "B",
      "predictive_power": 0.68,
      "cost_per_test": 150,
      "turnaround_time_days": 7,
      "insurance_coverage": "not-covered",
      "direction_with_age": "decreases",
      "notes": "Decreased copy number = mitochondrial depletion"
    },
    {
      "id": 27,
      "name": "ATP Production Capacity",
      "category": "mitochondrial",
      "subcategory": "energy_metabolism",
      "measurement_method": "Oroboros respirometry or Seahorse assay (muscle biopsy)",
      "specimen_type": "tissue",
      "normal_range_20s": {"relative": 100, "unit": "% of max"},
      "normal_range_40s": {"relative": 85, "unit": "% of max"},
      "normal_range_60s": {"relative": 73, "unit": "% of max"},
      "normal_range_80s": {"relative": 62, "unit": "% of max"},
      "clinical_validation_level": "research-use",
      "evidence_grade": "A",
      "predictive_power": 0.70,
      "cost_per_test": 800,
      "turnaround_time_days": 14,
      "insurance_coverage": "rarely-covered",
      "direction_with_age": "decreases",
      "notes": "~8% decline per decade in skeletal muscle. At age 70: ~60% of age 20 capacity"
    },
    {
      "id": 28,
      "name": "Grip Strength",
      "category": "cardiovascular",
      "subcategory": "functional_capacity",
      "measurement_method": "Hand dynamometer",
      "specimen_type": "imaging",
      "normal_range_20s": {"min": 40, "max": 60, "unit": "kg (men)"},
      "normal_range_40s": {"min": 38, "max": 55, "unit": "kg (men)"},
      "normal_range_60s": {"min": 32, "max": 45, "unit": "kg (men)"},
      "normal_range_80s": {"min": 25, "max": 35, "unit": "kg (men)"},
      "clinical_validation_level": "clinically-validated",
      "evidence_grade": "A",
      "predictive_power": 0.74,
      "cost_per_test": 10,
      "turnaround_time_days": 0,
      "insurance_coverage": "typically-covered",
      "direction_with_age": "decreases",
      "pathological_threshold": "<26 kg (men), <16 kg (women) = sarcopenia",
      "notes": "Strong predictor of all-cause mortality"
    },
    {
      "id": 29,
      "name": "Gait Speed",
      "category": "cardiovascular",
      "subcategory": "functional_capacity",
      "measurement_method": "4-meter walk test",
      "specimen_type": "imaging",
      "normal_range_20s": {"min": 1.2, "max": 1.5, "unit": "m/s"},
      "normal_range_40s": {"min": 1.1, "max": 1.4, "unit": "m/s"},
      "normal_range_60s": {"min": 1.0, "max": 1.3, "unit": "m/s"},
      "normal_range_80s": {"min": 0.7, "max": 1.0, "unit": "m/s"},
      "clinical_validation_level": "clinically-validated",
      "evidence_grade": "A",
      "predictive_power": 0.76,
      "cost_per_test": 5,
      "turnaround_time_days": 0,
      "insurance_coverage": "typically-covered",
      "direction_with_age": "decreases",
      "pathological_threshold": "<0.8 m/s (high mortality risk)",
      "notes": "Simple, powerful predictor of survival in older adults"
    },
    {
      "id": 30,
      "name": "SA-β-galactosidase Activity",
      "category": "cellular",
      "subcategory": "senescence",
      "measurement_method": "Histochemical staining (X-Gal) or flow cytometry (C12FDG)",
      "specimen_type": "tissue",
      "clinical_validation_level": "research-use",
      "evidence_grade": "B",
      "predictive_power": 0.60,
      "cost_per_test": 200,
      "turnaround_time_days": 7,
      "insurance_coverage": "not-covered",
      "direction_with_age": "increases",
      "notes": "Lysosomal β-galactosidase at pH 6.0. Not specific alone; requires ≥2 senescence markers (ICSA)"
    },
    {
      "id": 31,
      "name": "Plasma Protein Age (1,664 proteins)",
      "category": "proteomic",
      "subcategory": "aging_clock",
      "measurement_method": "SOMAscan aptamer proteomics (11,000 proteins)",
      "specimen_type": "blood",
      "clinical_validation_level": "research-use",
      "evidence_grade": "A",
      "predictive_power": 0.88,
      "cost_per_test": 2000,
      "turnaround_time_days": 21,
      "insurance_coverage": "not-covered",
      "direction_with_age": "increases",
      "notes": "1,664 proteins increase with age, 665 decrease. Non-linear aging at ~41, 60, 67 years"
    },
    {
      "id": 32,
      "name": "Organ-Specific Aging (Brain)",
      "category": "proteomic",
      "subcategory": "organ_aging",
      "measurement_method": "Plasma proteomics + machine learning",
      "specimen_type": "blood",
      "clinical_validation_level": "research-use",
      "evidence_grade": "A",
      "predictive_power": 0.80,
      "cost_per_test": 2000,
      "turnaround_time_days": 21,
      "insurance_coverage": "not-covered",
      "direction_with_age": "increases",
      "notes": "Predicts Alzheimer's risk. Performance comparable to pTau-181"
    },
    {
      "id": 33,
      "name": "Organ-Specific Aging (Heart)",
      "category": "proteomic",
      "subcategory": "organ_aging",
      "measurement_method": "Plasma proteomics + machine learning",
      "specimen_type": "blood",
      "clinical_validation_level": "research-use",
      "evidence_grade": "A",
      "predictive_power": 0.85,
      "hazard_ratio": 2.5,
      "cost_per_test": 2000,
      "turnaround_time_days": 21,
      "insurance_coverage": "not-covered",
      "direction_with_age": "increases",
      "notes": "250% increased heart failure risk with accelerated heart aging"
    },
    {
      "id": 34,
      "name": "γH2AX Foci (DNA Damage)",
      "category": "cellular",
      "subcategory": "DNA_integrity",
      "measurement_method": "Immunofluorescence microscopy",
      "specimen_type": "blood",
      "normal_range_20s": {"min": 0.5, "max": 1.0, "unit": "foci/nucleus"},
      "normal_range_40s": {"min": 2.0, "max": 4.0, "unit": "foci/nucleus"},
      "normal_range_60s": {"min": 5.0, "max": 7.5, "unit": "foci/nucleus"},
      "normal_range_80s": {"min": 10.0, "max": 12.0, "unit": "foci/nucleus"},
      "clinical_validation_level": "research-use",
      "evidence_grade": "A",
      "predictive_power": 0.72,
      "cost_per_test": 300,
      "turnaround_time_days": 7,
      "insurance_coverage": "not-covered",
      "direction_with_age": "increases",
      "notes": "Phosphorylated H2AX marks DNA double-strand breaks. 9.2x increase from age 20-80"
    },
    {
      "id": 35,
      "name": "Somatic Mutation Burden (Blood)",
      "category": "cellular",
      "subcategory": "DNA_integrity",
      "measurement_method": "Whole genome sequencing (WGS)",
      "specimen_type": "blood",
      "normal_range_20s": {"mutations": 280, "unit": "SNVs/cell"},
      "normal_range_40s": {"mutations": 560, "unit": "SNVs/cell"},
      "normal_range_60s": {"mutations": 840, "unit": "SNVs/cell"},
      "normal_range_80s": {"mutations": 1120, "unit": "SNVs/cell"},
      "clinical_validation_level": "research-use",
      "evidence_grade": "A",
      "predictive_power": 0.78,
      "cost_per_test": 1000,
      "turnaround_time_days": 30,
      "insurance_coverage": "not-covered",
      "direction_with_age": "increases",
      "notes": "14 SNVs/cell/year in fibroblasts. Linear accumulation"
    },
    {
      "id": 36,
      "name": "Advanced Glycation End-Products (AGEs)",
      "category": "metabolic",
      "subcategory": "protein_damage",
      "measurement_method": "HPLC-MS/MS (7 AGE structures)",
      "specimen_type": "blood",
      "clinical_validation_level": "research-use",
      "evidence_grade": "A",
      "predictive_power": 0.70,
      "cost_per_test": 400,
      "turnaround_time_days": 14,
      "insurance_coverage": "not-covered",
      "direction_with_age": "increases",
      "notes": "Excellent markers across ALL subcellular compartments. Non-enzymatic modifications accumulate with age"
    },
    {
      "id": 37,
      "name": "Protein Carbonylation",
      "category": "metabolic",
      "subcategory": "protein_damage",
      "measurement_method": "HPLC-MS/MS",
      "specimen_type": "blood",
      "clinical_validation_level": "research-use",
      "evidence_grade": "A",
      "predictive_power": 0.68,
      "cost_per_test": 350,
      "turnaround_time_days": 14,
      "insurance_coverage": "not-covered",
      "direction_with_age": "increases",
      "notes": "Irreversible PTM. Causative role in protein aggregation (experimentally proven)"
    },
    {
      "id": 38,
      "name": "8-oxo-dG (Oxidative DNA Damage)",
      "category": "cellular",
      "subcategory": "DNA_integrity",
      "measurement_method": "HPLC-MS/MS or ELISA",
      "specimen_type": "urine",
      "clinical_validation_level": "research-use",
      "evidence_grade": "A",
      "predictive_power": 0.71,
      "cost_per_test": 250,
      "turnaround_time_days": 7,
      "insurance_coverage": "not-covered",
      "direction_with_age": "increases",
      "notes": "Marker of oxidative DNA damage. Urinary excretion increases with age"
    },
    {
      "id": 39,
      "name": "IL-1β (Interleukin-1 beta)",
      "category": "inflammatory",
      "subcategory": "cytokine",
      "measurement_method": "ELISA or multiplex immunoassay",
      "specimen_type": "blood",
      "clinical_validation_level": "clinically-validated",
      "evidence_grade": "B",
      "predictive_power": 0.65,
      "cost_per_test": 80,
      "turnaround_time_days": 3,
      "insurance_coverage": "rarely-covered",
      "direction_with_age": "increases",
      "notes": "Key inflammasome-activated cytokine. NLRP3 inflammasome activation increases with age"
    },
    {
      "id": 40,
      "name": "IL-8 (Interleukin-8)",
      "category": "inflammatory",
      "subcategory": "cytokine",
      "measurement_method": "ELISA or multiplex immunoassay",
      "specimen_type": "blood",
      "clinical_validation_level": "clinically-validated",
      "evidence_grade": "B",
      "predictive_power": 0.66,
      "cost_per_test": 80,
      "turnaround_time_days": 3,
      "insurance_coverage": "rarely-covered",
      "direction_with_age": "increases",
      "notes": "Chemokine associated with inflammaging and SASP"
    },
    {
      "id": 41,
      "name": "Insulin (Fasting)",
      "category": "metabolic",
      "subcategory": "glycemic_control",
      "measurement_method": "Immunoassay",
      "specimen_type": "blood",
      "normal_range_20s": {"min": 2, "max": 10, "unit": "μIU/mL"},
      "normal_range_40s": {"min": 3, "max": 15, "unit": "μIU/mL"},
      "normal_range_60s": {"min": 5, "max": 20, "unit": "μIU/mL"},
      "normal_range_80s": {"min": 7, "max": 25, "unit": "μIU/mL"},
      "clinical_validation_level": "FDA-approved",
      "evidence_grade": "A",
      "predictive_power": 0.76,
      "cost_per_test": 30,
      "turnaround_time_days": 1,
      "insurance_coverage": "typically-covered",
      "direction_with_age": "increases",
      "pathological_threshold": ">25 μIU/mL (insulin resistance)",
      "notes": "Insulin resistance characteristic of aging. Combined with glucose for HOMA-IR"
    },
    {
      "id": 42,
      "name": "HOMA-IR (Insulin Resistance Index)",
      "category": "metabolic",
      "subcategory": "glycemic_control",
      "measurement_method": "Calculated: (fasting insulin × fasting glucose) / 405",
      "specimen_type": "blood",
      "normal_range_20s": {"min": 0.5, "max": 1.4, "unit": "unitless"},
      "normal_range_40s": {"min": 0.7, "max": 2.0, "unit": "unitless"},
      "normal_range_60s": {"min": 1.0, "max": 2.9, "unit": "unitless"},
      "normal_range_80s": {"min": 1.5, "max": 3.5, "unit": "unitless"},
      "clinical_validation_level": "clinically-validated",
      "evidence_grade": "A",
      "predictive_power": 0.79,
      "cost_per_test": 0,
      "turnaround_time_days": 0,
      "insurance_coverage": "typically-covered",
      "direction_with_age": "increases",
      "pathological_threshold": ">2.9 (insulin resistance)",
      "notes": "Gold standard surrogate for insulin sensitivity"
    },
    {
      "id": 43,
      "name": "Creatinine (Serum)",
      "category": "metabolic",
      "subcategory": "renal_function",
      "measurement_method": "Jaffe reaction or enzymatic",
      "specimen_type": "blood",
      "normal_range_20s": {"min": 0.6, "max": 1.2, "unit": "mg/dL"},
      "normal_range_40s": {"min": 0.7, "max": 1.3, "unit": "mg/dL"},
      "normal_range_60s": {"min": 0.8, "max": 1.4, "unit": "mg/dL"},
      "normal_range_80s": {"min": 0.9, "max": 1.5, "unit": "mg/dL"},
      "clinical_validation_level": "FDA-approved",
      "evidence_grade": "A",
      "predictive_power": 0.72,
      "cost_per_test": 10,
      "turnaround_time_days": 0,
      "insurance_coverage": "typically-covered",
      "direction_with_age": "variable",
      "pathological_threshold": ">1.5 mg/dL (reduced renal function)",
      "notes": "Used to calculate eGFR. Muscle mass affects interpretation"
    },
    {
      "id": 44,
      "name": "eGFR (Estimated Glomerular Filtration Rate)",
      "category": "metabolic",
      "subcategory": "renal_function",
      "measurement_method": "CKD-EPI equation (creatinine-based)",
      "specimen_type": "blood",
      "normal_range_20s": {"min": 90, "max": 120, "unit": "mL/min/1.73m²"},
      "normal_range_40s": {"min": 85, "max": 115, "unit": "mL/min/1.73m²"},
      "normal_range_60s": {"min": 75, "max": 100, "unit": "mL/min/1.73m²"},
      "normal_range_80s": {"min": 60, "max": 85, "unit": "mL/min/1.73m²"},
      "clinical_validation_level": "FDA-approved",
      "evidence_grade": "A",
      "predictive_power": 0.78,
      "cost_per_test": 0,
      "turnaround_time_days": 0,
      "insurance_coverage": "typically-covered",
      "direction_with_age": "decreases",
      "pathological_threshold": "<60 mL/min/1.73m² (CKD)",
      "notes": "~1 mL/min/1.73m² decline per year after age 40"
    },
    {
      "id": 45,
      "name": "Total Cholesterol",
      "category": "metabolic",
      "subcategory": "lipid_profile",
      "measurement_method": "Enzymatic colorimetric assay",
      "specimen_type": "blood",
      "clinical_validation_level": "FDA-approved",
      "evidence_grade": "A",
      "predictive_power": 0.70,
      "cost_per_test": 15,
      "turnaround_time_days": 1,
      "insurance_coverage": "typically-covered",
      "direction_with_age": "increases",
      "pathological_threshold": ">240 mg/dL (high risk)",
      "optimal_range": "<200 mg/dL",
      "notes": "Increases with age, peaks in 50s-60s, may decline in very elderly"
    },
    {
      "id": 46,
      "name": "LDL Cholesterol",
      "category": "metabolic",
      "subcategory": "lipid_profile",
      "measurement_method": "Direct assay or Friedewald equation",
      "specimen_type": "blood",
      "clinical_validation_level": "FDA-approved",
      "evidence_grade": "A",
      "predictive_power": 0.75,
      "cost_per_test": 15,
      "turnaround_time_days": 1,
      "insurance_coverage": "typically-covered",
      "direction_with_age": "increases",
      "pathological_threshold": ">160 mg/dL (high risk)",
      "optimal_range": "<100 mg/dL",
      "notes": "Primary target for CVD prevention"
    },
    {
      "id": 47,
      "name": "HDL Cholesterol",
      "category": "metabolic",
      "subcategory": "lipid_profile",
      "measurement_method": "Direct enzymatic assay",
      "specimen_type": "blood",
      "clinical_validation_level": "FDA-approved",
      "evidence_grade": "A",
      "predictive_power": 0.72,
      "cost_per_test": 15,
      "turnaround_time_days": 1,
      "insurance_coverage": "typically-covered",
      "direction_with_age": "stable",
      "pathological_threshold": "<40 mg/dL men, <50 mg/dL women (high risk)",
      "optimal_range": ">60 mg/dL",
      "notes": "Protective against CVD. Lower levels in elderly"
    },
    {
      "id": 48,
      "name": "Triglycerides",
      "category": "metabolic",
      "subcategory": "lipid_profile",
      "measurement_method": "Enzymatic colorimetric assay",
      "specimen_type": "blood",
      "clinical_validation_level": "FDA-approved",
      "evidence_grade": "A",
      "predictive_power": 0.68,
      "cost_per_test": 15,
      "turnaround_time_days": 1,
      "insurance_coverage": "typically-covered",
      "direction_with_age": "increases",
      "pathological_threshold": ">200 mg/dL (high risk)",
      "optimal_range": "<150 mg/dL",
      "notes": "Increases with age and metabolic syndrome"
    },
    {
      "id": 49,
      "name": "Mitochondrial ROS Production",
      "category": "mitochondrial",
      "subcategory": "oxidative_stress",
      "measurement_method": "Flow cytometry (MitoSOX or DHE)",
      "specimen_type": "blood",
      "clinical_validation_level": "research-use",
      "evidence_grade": "B",
      "predictive_power": 0.67,
      "cost_per_test": 250,
      "turnaround_time_days": 7,
      "insurance_coverage": "not-covered",
      "direction_with_age": "increases",
      "notes": "Mitochondrial superoxide increases with age, damages cellular components"
    },
    {
      "id": 50,
      "name": "Complex I Activity",
      "category": "mitochondrial",
      "subcategory": "respiratory_chain",
      "measurement_method": "Spectrophotometry (NADH oxidation)",
      "specimen_type": "tissue",
      "clinical_validation_level": "research-use",
      "evidence_grade": "A",
      "predictive_power": 0.69,
      "cost_per_test": 400,
      "turnaround_time_days": 14,
      "insurance_coverage": "not-covered",
      "direction_with_age": "decreases",
      "notes": "Primary site of mitochondrial dysfunction in aging"
    },
    {
      "id": 51,
      "name": "Complex IV Activity (Cytochrome c Oxidase)",
      "category": "mitochondrial",
      "subcategory": "respiratory_chain",
      "measurement_method": "Spectrophotometry",
      "specimen_type": "tissue",
      "clinical_validation_level": "research-use",
      "evidence_grade": "A",
      "predictive_power": 0.68,
      "cost_per_test": 400,
      "turnaround_time_days": 14,
      "insurance_coverage": "not-covered",
      "direction_with_age": "decreases",
      "notes": "Marker of mitochondrial function, declines with age"
    },
    {
      "id": 52,
      "name": "Melatonin (Nocturnal)",
      "category": "hormonal",
      "subcategory": "circadian",
      "measurement_method": "Immunoassay (saliva or serum)",
      "specimen_type": "saliva",
      "clinical_validation_level": "clinically-validated",
      "evidence_grade": "B",
      "predictive_power": 0.60,
      "cost_per_test": 100,
      "turnaround_time_days": 5,
      "insurance_coverage": "rarely-covered",
      "direction_with_age": "decreases",
      "notes": "Peak production declines with age. Important for circadian rhythm and sleep quality"
    },
    {
      "id": 53,
      "name": "Leptin",
      "category": "hormonal",
      "subcategory": "metabolic_hormone",
      "measurement_method": "ELISA",
      "specimen_type": "blood",
      "clinical_validation_level": "clinically-validated",
      "evidence_grade": "B",
      "predictive_power": 0.63,
      "cost_per_test": 80,
      "turnaround_time_days": 5,
      "insurance_coverage": "rarely-covered",
      "direction_with_age": "increases",
      "notes": "Increases with age and adiposity. Leptin resistance develops"
    },
    {
      "id": 54,
      "name": "Adiponectin",
      "category": "hormonal",
      "subcategory": "metabolic_hormone",
      "measurement_method": "ELISA",
      "specimen_type": "blood",
      "clinical_validation_level": "clinically-validated",
      "evidence_grade": "B",
      "predictive_power": 0.65,
      "cost_per_test": 100,
      "turnaround_time_days": 5,
      "insurance_coverage": "rarely-covered",
      "direction_with_age": "decreases",
      "notes": "Anti-inflammatory adipokine. Low levels predict metabolic syndrome"
    },
    {
      "id": 55,
      "name": "Free Thyroxine (FT4)",
      "category": "hormonal",
      "subcategory": "thyroid",
      "measurement_method": "Immunoassay",
      "specimen_type": "blood",
      "clinical_validation_level": "FDA-approved",
      "evidence_grade": "A",
      "predictive_power": 0.68,
      "cost_per_test": 40,
      "turnaround_time_days": 1,
      "insurance_coverage": "typically-covered",
      "direction_with_age": "decreases",
      "notes": "Active thyroid hormone. Levels decline with age"
    },
    {
      "id": 56,
      "name": "Free Triiodothyronine (FT3)",
      "category": "hormonal",
      "subcategory": "thyroid",
      "measurement_method": "Immunoassay",
      "specimen_type": "blood",
      "clinical_validation_level": "FDA-approved",
      "evidence_grade": "A",
      "predictive_power": 0.67,
      "cost_per_test": 50,
      "turnaround_time_days": 1,
      "insurance_coverage": "typically-covered",
      "direction_with_age": "decreases",
      "notes": "Most active thyroid hormone. Conversion from T4 declines with age"
    },
    {
      "id": 57,
      "name": "Growth Hormone (GH)",
      "category": "hormonal",
      "subcategory": "growth_hormone_axis",
      "measurement_method": "Immunoassay (stimulation test)",
      "specimen_type": "blood",
      "clinical_validation_level": "FDA-approved",
      "evidence_grade": "B",
      "predictive_power": 0.62,
      "cost_per_test": 150,
      "turnaround_time_days": 3,
      "insurance_coverage": "sometimes-covered",
      "direction_with_age": "decreases",
      "notes": "Pulsatile secretion declines ~14% per decade after puberty"
    },
    {
      "id": 58,
      "name": "Free Testosterone",
      "category": "hormonal",
      "subcategory": "sex_hormone",
      "measurement_method": "Calculated from total testosterone and SHBG",
      "specimen_type": "blood",
      "clinical_validation_level": "FDA-approved",
      "evidence_grade": "A",
      "predictive_power": 0.70,
      "cost_per_test": 75,
      "turnaround_time_days": 2,
      "insurance_coverage": "typically-covered",
      "direction_with_age": "decreases",
      "notes": "Bioavailable fraction. More accurate indicator of androgen status than total"
    },
    {
      "id": 59,
      "name": "SHBG (Sex Hormone-Binding Globulin)",
      "category": "hormonal",
      "subcategory": "sex_hormone",
      "measurement_method": "Immunoassay",
      "specimen_type": "blood",
      "clinical_validation_level": "FDA-approved",
      "evidence_grade": "A",
      "predictive_power": 0.65,
      "cost_per_test": 60,
      "turnaround_time_days": 2,
      "insurance_coverage": "typically-covered",
      "direction_with_age": "increases",
      "notes": "Increases with age, reducing free testosterone. Inversely correlates with insulin resistance"
    },
    {
      "id": 60,
      "name": "FSH (Follicle-Stimulating Hormone)",
      "category": "hormonal",
      "subcategory": "sex_hormone",
      "measurement_method": "Immunoassay",
      "specimen_type": "blood",
      "clinical_validation_level": "FDA-approved",
      "evidence_grade": "A",
      "predictive_power": 0.72,
      "cost_per_test": 50,
      "turnaround_time_days": 2,
      "insurance_coverage": "typically-covered",
      "direction_with_age": "increases",
      "pathological_threshold": ">30 mIU/mL (menopause in women)",
      "notes": "Rises dramatically with ovarian aging in women"
    },
    {
      "id": 61,
      "name": "LH (Luteinizing Hormone)",
      "category": "hormonal",
      "subcategory": "sex_hormone",
      "measurement_method": "Immunoassay",
      "specimen_type": "blood",
      "clinical_validation_level": "FDA-approved",
      "evidence_grade": "A",
      "predictive_power": 0.68,
      "cost_per_test": 50,
      "turnaround_time_days": 2,
      "insurance_coverage": "typically-covered",
      "direction_with_age": "increases",
      "notes": "Rises with age due to gonadal decline"
    },
    {
      "id": 62,
      "name": "Homocysteine",
      "category": "metabolic",
      "subcategory": "vascular_health",
      "measurement_method": "Immunoassay or HPLC",
      "specimen_type": "blood",
      "clinical_validation_level": "FDA-approved",
      "evidence_grade": "A",
      "predictive_power": 0.70,
      "cost_per_test": 50,
      "turnaround_time_days": 2,
      "insurance_coverage": "sometimes-covered",
      "direction_with_age": "increases",
      "pathological_threshold": ">15 μmol/L (CVD risk)",
      "optimal_range": "<10 μmol/L",
      "notes": "Rises with age, B-vitamin deficiency. Independent CVD risk factor"
    },
    {
      "id": 63,
      "name": "Albumin (Serum)",
      "category": "metabolic",
      "subcategory": "nutrition",
      "measurement_method": "Bromocresol green or purple method",
      "specimen_type": "blood",
      "normal_range_20s": {"min": 4.0, "max": 5.5, "unit": "g/dL"},
      "normal_range_40s": {"min": 3.9, "max": 5.3, "unit": "g/dL"},
      "normal_range_60s": {"min": 3.7, "max": 5.0, "unit": "g/dL"},
      "normal_range_80s": {"min": 3.5, "max": 4.8, "unit": "g/dL"},
      "clinical_validation_level": "FDA-approved",
      "evidence_grade": "A",
      "predictive_power": 0.73,
      "cost_per_test": 10,
      "turnaround_time_days": 0,
      "insurance_coverage": "typically-covered",
      "direction_with_age": "decreases",
      "pathological_threshold": "<3.5 g/dL (malnutrition)",
      "notes": "Declines with age. Strong predictor of mortality in elderly"
    },
    {
      "id": 64,
      "name": "Prealbumin (Transthyretin)",
      "category": "metabolic",
      "subcategory": "nutrition",
      "measurement_method": "Immunoassay",
      "specimen_type": "blood",
      "clinical_validation_level": "FDA-approved",
      "evidence_grade": "B",
      "predictive_power": 0.68,
      "cost_per_test": 40,
      "turnaround_time_days": 1,
      "insurance_coverage": "sometimes-covered",
      "direction_with_age": "decreases",
      "pathological_threshold": "<20 mg/dL (malnutrition)",
      "notes": "More sensitive than albumin for nutritional status"
    },
    {
      "id": 65,
      "name": "Ferritin",
      "category": "metabolic",
      "subcategory": "iron_metabolism",
      "measurement_method": "Immunoassay",
      "specimen_type": "blood",
      "clinical_validation_level": "FDA-approved",
      "evidence_grade": "A",
      "predictive_power": 0.65,
      "cost_per_test": 30,
      "turnaround_time_days": 1,
      "insurance_coverage": "typically-covered",
      "direction_with_age": "increases",
      "pathological_threshold": ">300 ng/mL (iron overload risk)",
      "notes": "Increases with age. High levels associated with inflammation and oxidative stress"
    },
    {
      "id": 66,
      "name": "Neutrophil-to-Lymphocyte Ratio (NLR)",
      "category": "inflammatory",
      "subcategory": "immune_function",
      "measurement_method": "Calculated from CBC",
      "specimen_type": "blood",
      "clinical_validation_level": "clinically-validated",
      "evidence_grade": "A",
      "predictive_power": 0.74,
      "cost_per_test": 0,
      "turnaround_time_days": 0,
      "insurance_coverage": "typically-covered",
      "direction_with_age": "increases",
      "pathological_threshold": ">3.0 (elevated inflammation)",
      "optimal_range": "1.0-2.0",
      "notes": "Simple, powerful inflammatory marker. Predicts mortality, CVD, and cancer"
    },
    {
      "id": 67,
      "name": "CD4+/CD8+ T-cell Ratio",
      "category": "inflammatory",
      "subcategory": "immune_function",
      "measurement_method": "Flow cytometry",
      "specimen_type": "blood",
      "normal_range_20s": {"min": 1.5, "max": 2.5, "unit": "ratio"},
      "normal_range_40s": {"min": 1.2, "max": 2.3, "unit": "ratio"},
      "normal_range_60s": {"min": 1.0, "max": 2.0, "unit": "ratio"},
      "normal_range_80s": {"min": 0.8, "max": 1.8, "unit": "ratio"},
      "clinical_validation_level": "FDA-approved",
      "evidence_grade": "A",
      "predictive_power": 0.71,
      "cost_per_test": 150,
      "turnaround_time_days": 3,
      "insurance_coverage": "sometimes-covered",
      "direction_with_age": "decreases",
      "pathological_threshold": "<1.0 (immune senescence)",
      "notes": "Inverted ratio indicates immunosenescence. CD8+ expansion with age"
    },
    {
      "id": 68,
      "name": "Naive T-cell Percentage",
      "category": "inflammatory",
      "subcategory": "immune_function",
      "measurement_method": "Flow cytometry (CD45RA+CCR7+)",
      "specimen_type": "blood",
      "clinical_validation_level": "research-use",
      "evidence_grade": "B",
      "predictive_power": 0.68,
      "cost_per_test": 200,
      "turnaround_time_days": 5,
      "insurance_coverage": "not-covered",
      "direction_with_age": "decreases",
      "notes": "Declines with age due to thymic involution. Limits response to novel pathogens"
    },
    {
      "id": 69,
      "name": "Klotho (Serum)",
      "category": "proteomic",
      "subcategory": "longevity_factor",
      "measurement_method": "ELISA",
      "specimen_type": "blood",
      "clinical_validation_level": "research-use",
      "evidence_grade": "A",
      "predictive_power": 0.72,
      "cost_per_test": 250,
      "turnaround_time_days": 14,
      "insurance_coverage": "not-covered",
      "direction_with_age": "decreases",
      "notes": "Anti-aging protein. Regulates phosphate metabolism, insulin signaling, and oxidative stress"
    },
    {
      "id": 70,
      "name": "Cystatin C",
      "category": "metabolic",
      "subcategory": "renal_function",
      "measurement_method": "Immunoassay",
      "specimen_type": "blood",
      "clinical_validation_level": "FDA-approved",
      "evidence_grade": "A",
      "predictive_power": 0.76,
      "cost_per_test": 50,
      "turnaround_time_days": 1,
      "insurance_coverage": "sometimes-covered",
      "direction_with_age": "increases",
      "notes": "Superior to creatinine for eGFR. Not affected by muscle mass"
    },
    {
      "id": 71,
      "name": "NT-proBNP (N-terminal pro-B-type Natriuretic Peptide)",
      "category": "cardiovascular",
      "subcategory": "cardiac_function",
      "measurement_method": "Immunoassay",
      "specimen_type": "blood",
      "clinical_validation_level": "FDA-approved",
      "evidence_grade": "A",
      "predictive_power": 0.82,
      "cost_per_test": 75,
      "turnaround_time_days": 1,
      "insurance_coverage": "typically-covered",
      "direction_with_age": "increases",
      "pathological_threshold": ">125 pg/mL (<75 years), >450 pg/mL (≥75 years)",
      "notes": "Gold standard biomarker for heart failure. Increases with age and cardiac stress"
    },
    {
      "id": 72,
      "name": "Troponin I (High-Sensitivity)",
      "category": "cardiovascular",
      "subcategory": "cardiac_injury",
      "measurement_method": "High-sensitivity immunoassay",
      "specimen_type": "blood",
      "clinical_validation_level": "FDA-approved",
      "evidence_grade": "A",
      "predictive_power": 0.85,
      "cost_per_test": 50,
      "turnaround_time_days": 0,
      "insurance_coverage": "typically-covered",
      "direction_with_age": "increases",
      "pathological_threshold": ">99th percentile for age (cardiac injury)",
      "notes": "Detects subclinical cardiac injury. Baseline levels rise with age"
    },
    {
      "id": 73,
      "name": "Lipoprotein(a) [Lp(a)]",
      "category": "metabolic",
      "subcategory": "lipid_profile",
      "measurement_method": "Immunoturbidimetric assay",
      "specimen_type": "blood",
      "clinical_validation_level": "FDA-approved",
      "evidence_grade": "A",
      "predictive_power": 0.73,
      "cost_per_test": 50,
      "turnaround_time_days": 2,
      "insurance_coverage": "sometimes-covered",
      "direction_with_age": "stable",
      "pathological_threshold": ">50 mg/dL (high CVD risk)",
      "optimal_range": "<30 mg/dL",
      "notes": "Genetically determined, stable across life. Independent CVD risk factor"
    },
    {
      "id": 74,
      "name": "ApoB (Apolipoprotein B)",
      "category": "metabolic",
      "subcategory": "lipid_profile",
      "measurement_method": "Immunoassay",
      "specimen_type": "blood",
      "clinical_validation_level": "FDA-approved",
      "evidence_grade": "A",
      "predictive_power": 0.77,
      "cost_per_test": 60,
      "turnaround_time_days": 2,
      "insurance_coverage": "sometimes-covered",
      "direction_with_age": "increases",
      "pathological_threshold": ">130 mg/dL (high CVD risk)",
      "optimal_range": "<90 mg/dL",
      "notes": "Superior to LDL for CVD risk. One ApoB per atherogenic particle"
    },
    {
      "id": 75,
      "name": "Uric Acid",
      "category": "metabolic",
      "subcategory": "purine_metabolism",
      "measurement_method": "Uricase enzymatic assay",
      "specimen_type": "blood",
      "clinical_validation_level": "FDA-approved",
      "evidence_grade": "A",
      "predictive_power": 0.68,
      "cost_per_test": 15,
      "turnaround_time_days": 0,
      "insurance_coverage": "typically-covered",
      "direction_with_age": "increases",
      "pathological_threshold": ">7.0 mg/dL (gout risk)",
      "notes": "Increases with age, metabolic syndrome. Also an antioxidant"
    },
    {
      "id": 76,
      "name": "ALT (Alanine Aminotransferase)",
      "category": "metabolic",
      "subcategory": "liver_function",
      "measurement_method": "Enzymatic assay",
      "specimen_type": "blood",
      "clinical_validation_level": "FDA-approved",
      "evidence_grade": "A",
      "predictive_power": 0.65,
      "cost_per_test": 15,
      "turnaround_time_days": 0,
      "insurance_coverage": "typically-covered",
      "direction_with_age": "increases",
      "pathological_threshold": ">40 U/L (liver injury)",
      "notes": "Elevated levels common with NAFLD, which increases with age"
    },
    {
      "id": 77,
      "name": "AST (Aspartate Aminotransferase)",
      "category": "metabolic",
      "subcategory": "liver_function",
      "measurement_method": "Enzymatic assay",
      "specimen_type": "blood",
      "clinical_validation_level": "FDA-approved",
      "evidence_grade": "A",
      "predictive_power": 0.63,
      "cost_per_test": 15,
      "turnaround_time_days": 0,
      "insurance_coverage": "typically-covered",
      "direction_with_age": "increases",
      "pathological_threshold": ">40 U/L (tissue injury)",
      "notes": "AST/ALT ratio useful for differentiating liver conditions"
    },
    {
      "id": 78,
      "name": "GGT (Gamma-Glutamyl Transferase)",
      "category": "metabolic",
      "subcategory": "liver_function",
      "measurement_method": "Enzymatic assay",
      "specimen_type": "blood",
      "clinical_validation_level": "FDA-approved",
      "evidence_grade": "A",
      "predictive_power": 0.70,
      "cost_per_test": 20,
      "turnaround_time_days": 0,
      "insurance_coverage": "typically-covered",
      "direction_with_age": "increases",
      "pathological_threshold": ">60 U/L (liver/biliary disease)",
      "notes": "Marker of oxidative stress and alcohol consumption. Predicts CVD and mortality"
    },
    {
      "id": 79,
      "name": "Hemoglobin",
      "category": "metabolic",
      "subcategory": "hematology",
      "measurement_method": "Automated cell counter",
      "specimen_type": "blood",
      "normal_range_20s": {"min": 13.5, "max": 17.5, "unit": "g/dL (men)"},
      "normal_range_40s": {"min": 13.0, "max": 17.0, "unit": "g/dL (men)"},
      "normal_range_60s": {"min": 12.5, "max": 16.5, "unit": "g/dL (men)"},
      "normal_range_80s": {"min": 12.0, "max": 16.0, "unit": "g/dL (men)"},
      "clinical_validation_level": "FDA-approved",
      "evidence_grade": "A",
      "predictive_power": 0.71,
      "cost_per_test": 10,
      "turnaround_time_days": 0,
      "insurance_coverage": "typically-covered",
      "direction_with_age": "decreases",
      "pathological_threshold": "<12 g/dL men, <11 g/dL women (anemia)",
      "notes": "Mild decline with age. Anemia common in elderly"
    },
    {
      "id": 80,
      "name": "White Blood Cell Count",
      "category": "inflammatory",
      "subcategory": "immune_function",
      "measurement_method": "Automated cell counter",
      "specimen_type": "blood",
      "clinical_validation_level": "FDA-approved",
      "evidence_grade": "A",
      "predictive_power": 0.67,
      "cost_per_test": 10,
      "turnaround_time_days": 0,
      "insurance_coverage": "typically-covered",
      "direction_with_age": "decreases",
      "pathological_threshold": "<4,000/μL (leukopenia), >11,000/μL (leukocytosis)",
      "notes": "Total count may decline. Shifts in differential (increased neutrophils, decreased lymphocytes)"
    },
    {
      "id": 81,
      "name": "Platelet Count",
      "category": "metabolic",
      "subcategory": "hematology",
      "measurement_method": "Automated cell counter",
      "specimen_type": "blood",
      "clinical_validation_level": "FDA-approved",
      "evidence_grade": "A",
      "predictive_power": 0.62,
      "cost_per_test": 10,
      "turnaround_time_days": 0,
      "insurance_coverage": "typically-covered",
      "direction_with_age": "stable",
      "pathological_threshold": "<150,000/μL (thrombocytopenia)",
      "notes": "Generally stable with age. Low count increases bleeding risk"
    },
    {
      "id": 82,
      "name": "Bone Mineral Density (BMD)",
      "category": "cardiovascular",
      "subcategory": "musculoskeletal",
      "measurement_method": "DEXA scan (T-score)",
      "specimen_type": "imaging",
      "clinical_validation_level": "FDA-approved",
      "evidence_grade": "A",
      "predictive_power": 0.80,
      "cost_per_test": 150,
      "turnaround_time_days": 0,
      "insurance_coverage": "typically-covered",
      "direction_with_age": "decreases",
      "pathological_threshold": "T-score < -2.5 (osteoporosis)",
      "optimal_range": "T-score > -1.0",
      "notes": "Accelerated loss postmenopause (women) and after age 70 (both sexes)"
    },
    {
      "id": 83,
      "name": "Vitamin B12",
      "category": "metabolic",
      "subcategory": "nutrition",
      "measurement_method": "Immunoassay",
      "specimen_type": "blood",
      "clinical_validation_level": "FDA-approved",
      "evidence_grade": "A",
      "predictive_power": 0.65,
      "cost_per_test": 30,
      "turnaround_time_days": 1,
      "insurance_coverage": "typically-covered",
      "direction_with_age": "decreases",
      "pathological_threshold": "<200 pg/mL (deficiency)",
      "optimal_range": ">400 pg/mL",
      "notes": "Deficiency common in elderly due to reduced absorption"
    },
    {
      "id": 84,
      "name": "Folate (Serum)",
      "category": "metabolic",
      "subcategory": "nutrition",
      "measurement_method": "Immunoassay",
      "specimen_type": "blood",
      "clinical_validation_level": "FDA-approved",
      "evidence_grade": "A",
      "predictive_power": 0.62,
      "cost_per_test": 30,
      "turnaround_time_days": 1,
      "insurance_coverage": "typically-covered",
      "direction_with_age": "stable",
      "pathological_threshold": "<3 ng/mL (deficiency)",
      "notes": "Important for DNA synthesis and homocysteine metabolism"
    },
    {
      "id": 85,
      "name": "Serum Amyloid A (SAA)",
      "category": "inflammatory",
      "subcategory": "acute_phase",
      "measurement_method": "ELISA or immunoassay",
      "specimen_type": "blood",
      "clinical_validation_level": "clinically-validated",
      "evidence_grade": "B",
      "predictive_power": 0.69,
      "cost_per_test": 100,
      "turnaround_time_days": 3,
      "insurance_coverage": "rarely-covered",
      "direction_with_age": "increases",
      "notes": "Acute phase protein, increases with inflammation and infection"
    },
    {
      "id": 86,
      "name": "Fibrinogen",
      "category": "inflammatory",
      "subcategory": "coagulation",
      "measurement_method": "Clauss method",
      "specimen_type": "blood",
      "clinical_validation_level": "FDA-approved",
      "evidence_grade": "A",
      "predictive_power": 0.72,
      "cost_per_test": 30,
      "turnaround_time_days": 1,
      "insurance_coverage": "typically-covered",
      "direction_with_age": "increases",
      "pathological_threshold": ">400 mg/dL (thrombotic risk)",
      "notes": "Acute phase reactant. High levels predict CVD events"
    },
    {
      "id": 87,
      "name": "D-dimer",
      "category": "inflammatory",
      "subcategory": "coagulation",
      "measurement_method": "Immunoassay",
      "specimen_type": "blood",
      "clinical_validation_level": "FDA-approved",
      "evidence_grade": "A",
      "predictive_power": 0.70,
      "cost_per_test": 50,
      "turnaround_time_days": 0,
      "insurance_coverage": "typically-covered",
      "direction_with_age": "increases",
      "pathological_threshold": ">500 ng/mL (thrombosis)",
      "notes": "Fibrin degradation product. Baseline increases with age"
    },
    {
      "id": 88,
      "name": "MicroRNA-21 (miR-21)",
      "category": "genetic",
      "subcategory": "epigenetic_regulation",
      "measurement_method": "RT-qPCR",
      "specimen_type": "blood",
      "clinical_validation_level": "research-use",
      "evidence_grade": "B",
      "predictive_power": 0.68,
      "cost_per_test": 200,
      "turnaround_time_days": 14,
      "insurance_coverage": "not-covered",
      "direction_with_age": "increases",
      "notes": "Upregulated with age and cellular senescence. Pro-inflammatory SASP factor"
    },
    {
      "id": 89,
      "name": "Hannum DNAm Clock",
      "category": "epigenetic",
      "subcategory": "methylation_clock",
      "measurement_method": "DNA methylation array (71 CpG sites)",
      "specimen_type": "blood",
      "clinical_validation_level": "clinically-validated",
      "evidence_grade": "A",
      "predictive_power": 0.83,
      "cost_per_test": 300,
      "turnaround_time_days": 14,
      "insurance_coverage": "rarely-covered",
      "direction_with_age": "increases",
      "notes": "Blood-specific clock. Accuracy ±3.9 years. Predicts mortality and age-related disease"
    }
  ]
}